| __timestamp | Protagonist Therapeutics, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 1860000 | 2999000 |
| Thursday, January 1, 2015 | 2963000 | 10393000 |
| Friday, January 1, 2016 | 6961000 | 15994000 |
| Sunday, January 1, 2017 | 11779000 | 26975000 |
| Monday, January 1, 2018 | 13697000 | 39509000 |
| Tuesday, January 1, 2019 | 15749000 | 48869000 |
| Wednesday, January 1, 2020 | 18638000 | 42510000 |
| Friday, January 1, 2021 | 27196000 | 46105000 |
| Saturday, January 1, 2022 | 31739000 | 50513000 |
| Sunday, January 1, 2023 | 33491000 | 51292000 |
Unleashing insights
In the competitive world of biotechnology, managing operational costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of Protagonist Therapeutics, Inc. and Wave Life Sciences Ltd. from 2014 to 2023. Over this period, Wave Life Sciences consistently outspent Protagonist Therapeutics, with SG&A expenses peaking at approximately $51 million in 2023, a 71% increase from 2014. In contrast, Protagonist Therapeutics saw a more dramatic rise, with expenses growing by over 1,700% from 2014 to 2023, reaching around $33 million. This significant growth reflects the company's expansion and increased operational activities. Understanding these trends provides insight into each company's strategic priorities and financial health, offering a glimpse into their future trajectories in the biotech industry.
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Bristol-Myers Squibb Company and Wave Life Sciences Ltd.
Comparing SG&A Expenses: Gilead Sciences, Inc. vs Protagonist Therapeutics, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? GSK plc or Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing argenx SE and Protagonist Therapeutics, Inc.
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Wave Life Sciences Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? Insmed Incorporated or Wave Life Sciences Ltd.
Selling, General, and Administrative Costs: BioMarin Pharmaceutical Inc. vs Wave Life Sciences Ltd.
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Wave Life Sciences Ltd. Trends and Insights
SG&A Efficiency Analysis: Comparing Opthea Limited and Protagonist Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Verona Pharma plc and Protagonist Therapeutics, Inc.
Comparing SG&A Expenses: Vericel Corporation vs Wave Life Sciences Ltd. Trends and Insights